Vaccinex Stock Price on December 17, 2024
| VCNX Stock | USD 1.12 0.02 1.82% |
Below is the normalized historical share price chart for Vaccinex extending back to August 09, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Vaccinex stands at 1.12, as last reported on the 28th of December, with the highest price reaching 1.13 and the lowest price hitting 1.12 during the day.
If you're considering investing in Vaccinex Stock, it is important to understand the factors that can impact its price. Vaccinex owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0575, which indicates the firm had a -0.0575% return per unit of risk over the last 3 months. Vaccinex exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vaccinex's Coefficient Of Variation of (1,810), variance of 149.43, and Risk Adjusted Performance of (0.03) to confirm the risk estimate we provide.
Vaccinex Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 9th of August 2018 | 200 Day MA 5.097 | 50 Day MA 3.1326 | Beta 0.985 |
Vaccinex |
Sharpe Ratio = -0.0575
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VCNX |
Estimated Market Risk
| 12.5 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.72 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Vaccinex is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vaccinex by adding Vaccinex to a well-diversified portfolio.
Price Book 7.3409 | Enterprise Value Ebitda (0.72) | Price Sales 4.3798 | Shares Float 934.5 K | Wall Street Target Price 7 |
Vaccinex Main Headline on 17th of December 2024
Vaccinex Faces Nasdaq Delisting Amid Financial Struggles Sha... by gurufocus.com
Following breaching minimal listing criteria, Vaccinex will be delisted from Nasdaq, the firm said. As the company negotiates clinical trial
Vaccinex Valuation on December 17, 2024
It is possible to determine the worth of Vaccinex on a given historical date. On December 17, 2024 Vaccinex was worth 1.94 at the beginning of the trading date compared to the closed value of 1.41. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Vaccinex stock. Still, in general, we apply an absolute valuation method to find Vaccinex's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vaccinex where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Vaccinex's related companies.
| Open | High | Low | Close | Volume | |
| 3.73 | 4.04 | 3.52 | 3.65 | 22,092 | |
12/17/2024 | 1.94 | 2.00 | 1.24 | 1.41 | 758,951 |
| 1.40 | 1.41 | 1.05 | 1.06 | 94,871 |
| Backtest Vaccinex | | | Vaccinex History | | | Vaccinex Valuation | Previous | Next |
Vaccinex Trading Date Momentum on December 17, 2024
| On December 18 2024 Vaccinex was traded for 1.06 at the closing time. The top price for the day was 1.41 and the lowest listed price was 1.05 . The trading volume for the day was 94.9 K. The trading history from December 18, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 24.82% . The trading price change against the current closing price is 20.57% . |
Vaccinex Fundamentals Correlations and Trends
By evaluating Vaccinex's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Vaccinex's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Vaccinex financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Vaccinex Stock history
Vaccinex investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vaccinex is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vaccinex will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vaccinex stock prices may prove useful in developing a viable investing in Vaccinex
Vaccinex, Inc., a clinical-stage biotechnology company, focuses on treating cancer and neurodegenerative disease through the inhibition of semaphorin 4D . Vaccinex, Inc. was incorporated in 2001 and is headquartered in Rochester, New York. Vaccinex operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs people.
Vaccinex Stock Technical Analysis
Vaccinex technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Vaccinex Period Price Range
Low | December 28, 2024
| High |
0.00 | 0.00 |
Vaccinex cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Vaccinex December 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Vaccinex stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vaccinex shares will generate the highest return on investment. By undertsting and applying Vaccinex stock market strength indicators, traders can identify Vaccinex entry and exit signals to maximize returns
Vaccinex Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Vaccinex's price direction in advance. Along with the technical and fundamental analysis of Vaccinex Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vaccinex to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.76) | |||
| Total Risk Alpha | (1.03) | |||
| Treynor Ratio | (0.22) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Vaccinex Stock Analysis
When running Vaccinex's price analysis, check to measure Vaccinex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaccinex is operating at the current time. Most of Vaccinex's value examination focuses on studying past and present price action to predict the probability of Vaccinex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaccinex's price. Additionally, you may evaluate how the addition of Vaccinex to your portfolios can decrease your overall portfolio volatility.